vs
Side-by-side financial comparison of IMMERSION CORP (IMMR) and Bio-Techne (TECH). Click either name above to swap in a different company.
IMMERSION CORP is the larger business by last-quarter revenue ($372.9M vs $295.9M, roughly 1.3× Bio-Techne). Bio-Techne runs the higher net margin — 12.8% vs -4.6%, a 17.4% gap on every dollar of revenue. On growth, IMMERSION CORP posted the faster year-over-year revenue change (750.4% vs -6.4%). Over the past eight quarters, IMMERSION CORP's revenue compounded faster (537.9% CAGR vs 4.2%).
Immersion Corporation is an Aventura, Florida based developer and licensor of touch feedback technology, also known as haptic technology. Immersion Corporation has been accused of being a patent troll. Founded in 1993 by Louis Rosenberg, it is currently headed by lawyer Francis Jose, who serves as both chief executive officer and general counsel.
Bio-Techne Corporation is an American life sciences company that develops, manufactures and sells life science reagents, instruments and services for the research, diagnostic, and bioprocessing markets.
IMMR vs TECH — Head-to-Head
Income Statement — Q4 FY2025 vs Q2 FY2026
| Metric | | |
|---|---|---|
| Revenue | $372.9M | $295.9M |
| Net Profit | $-17.0M | $38.0M |
| Gross Margin | — | 64.6% |
| Operating Margin | -2.8% | 18.4% |
| Net Margin | -4.6% | 12.8% |
| Revenue YoY | 750.4% | -6.4% |
| Net Profit YoY | -191.3% | 68.3% |
| EPS (diluted) | $-0.57 | $0.24 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | — | $295.9M | ||
| Q2 25 | $372.9M | $317.0M | ||
| Q1 25 | $471.3M | $316.2M | ||
| Q4 24 | $616.2M | $297.0M | ||
| Q3 24 | — | $289.5M | ||
| Q2 24 | $95.5M | $306.1M | ||
| Q1 24 | $43.8M | $303.4M | ||
| Q4 23 | — | $272.6M |
| Q4 25 | — | $38.0M | ||
| Q2 25 | $-17.0M | $-17.7M | ||
| Q1 25 | $24.1M | $22.6M | ||
| Q4 24 | $30.8M | $34.9M | ||
| Q3 24 | — | $33.6M | ||
| Q2 24 | $26.4M | $40.6M | ||
| Q1 24 | $18.7M | $49.1M | ||
| Q4 23 | — | $27.5M |
| Q4 25 | — | 64.6% | ||
| Q2 25 | — | 62.7% | ||
| Q1 25 | — | 67.9% | ||
| Q4 24 | — | 65.3% | ||
| Q3 24 | — | 63.2% | ||
| Q2 24 | — | 66.4% | ||
| Q1 24 | — | 67.4% | ||
| Q4 23 | — | 64.8% |
| Q4 25 | — | 18.4% | ||
| Q2 25 | -2.8% | -7.5% | ||
| Q1 25 | 7.5% | 12.2% | ||
| Q4 24 | 11.4% | 16.0% | ||
| Q3 24 | — | 13.8% | ||
| Q2 24 | 23.7% | 15.0% | ||
| Q1 24 | 37.9% | 22.1% | ||
| Q4 23 | — | 13.9% |
| Q4 25 | — | 12.8% | ||
| Q2 25 | -4.6% | -5.6% | ||
| Q1 25 | 5.1% | 7.1% | ||
| Q4 24 | 5.0% | 11.7% | ||
| Q3 24 | — | 11.6% | ||
| Q2 24 | 27.7% | 13.3% | ||
| Q1 24 | 42.5% | 16.2% | ||
| Q4 23 | — | 10.1% |
| Q4 25 | — | $0.24 | ||
| Q2 25 | $-0.57 | $-0.11 | ||
| Q1 25 | $0.73 | $0.14 | ||
| Q4 24 | $0.93 | $0.22 | ||
| Q3 24 | — | $0.21 | ||
| Q2 24 | $0.81 | $0.26 | ||
| Q1 24 | $0.59 | $0.31 | ||
| Q4 23 | — | $0.17 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $161.4M | $172.9M |
| Total DebtLower is stronger | $103.1M | $260.0M |
| Stockholders' EquityBook value | $298.1M | $2.0B |
| Total Assets | $1.1B | $2.5B |
| Debt / EquityLower = less leverage | 0.35× | 0.13× |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | — | $172.9M | ||
| Q2 25 | $161.4M | $162.2M | ||
| Q1 25 | $153.9M | $140.7M | ||
| Q4 24 | $159.3M | $177.5M | ||
| Q3 24 | — | $187.5M | ||
| Q2 24 | $133.4M | $152.9M | ||
| Q1 24 | $179.1M | $145.3M | ||
| Q4 23 | — | $135.7M |
| Q4 25 | — | $260.0M | ||
| Q2 25 | $103.1M | $346.0M | ||
| Q1 25 | — | $330.0M | ||
| Q4 24 | — | $300.0M | ||
| Q3 24 | — | $300.0M | ||
| Q2 24 | — | $319.0M | ||
| Q1 24 | — | $389.0M | ||
| Q4 23 | — | $447.0M |
| Q4 25 | — | $2.0B | ||
| Q2 25 | $298.1M | $1.9B | ||
| Q1 25 | $317.9M | $2.0B | ||
| Q4 24 | $305.5M | $2.1B | ||
| Q3 24 | — | $2.1B | ||
| Q2 24 | $273.4M | $2.1B | ||
| Q1 24 | $201.5M | $2.0B | ||
| Q4 23 | — | $2.0B |
| Q4 25 | — | $2.5B | ||
| Q2 25 | $1.1B | $2.6B | ||
| Q1 25 | $1.4B | $2.6B | ||
| Q4 24 | $1.4B | $2.7B | ||
| Q3 24 | — | $2.7B | ||
| Q2 24 | $1.2B | $2.7B | ||
| Q1 24 | $244.7M | $2.7B | ||
| Q4 23 | — | $2.7B |
| Q4 25 | — | 0.13× | ||
| Q2 25 | 0.35× | 0.18× | ||
| Q1 25 | — | 0.16× | ||
| Q4 24 | — | 0.14× | ||
| Q3 24 | — | 0.14× | ||
| Q2 24 | — | 0.15× | ||
| Q1 24 | — | 0.19× | ||
| Q4 23 | — | 0.23× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
IMMR
| Course Material Sale | $150.9M | 40% |
| General Merchandise Sale | $138.0M | 37% |
| Rental Services | $51.8M | 14% |
| Services And Other Revenue | $25.6M | 7% |
| Per Unit Royalties | $1.8M | 0% |
TECH
| Diagnostics And Spatial Biology | $81.2M | 27% |
| EMEA Excluding UK | $75.4M | 25% |
| Other | $42.4M | 14% |
| Instruments | $29.6M | 10% |
| APAC Excluding Greater China | $22.7M | 8% |
| Services | $22.3M | 8% |
| GB | $13.7M | 5% |
| Royalty | $8.5M | 3% |
